An Inhibitor of Serine Proteases, Neuroserpin, Acts as a Neuroprotective Agent in a Mouse Model of Neurodegenerative Disease
Authors:
- Yannick SimoninYannick Simonin
- Yves CharronYCYves Charron
- Peter SondereggerPSPeter Sonderegger
- Jean-Dominique VassalliJVJean-Dominique Vassalli
- Ann C. KatoAKAnn C. Kato
Open Access
- 11 October 2006
- journal article
- research article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 26 (41) , 10614-10619
Abstract
Various studies suggest that proteolytic activity may be involved in a number of neurodegenerative disorders, including stroke and seizure. In this report, we examined the role of tryptic serine proteases, plasminogen activators (PAs), in the evolution of a neurodegenerative disease. Transgenic mice overexpressing an axonally secreted inhibitor of serine proteases (neuroserpin) were crossed with mice characterized by a "dying-back" motor neuron disease [progressive motor neuronopathy (pmn/pmn)]. Compared with pmn/pmn mice that showed an increase in PA activity, double mutant mice had decreased PA activity in sciatic nerves and spinal cord; their lifespan was increased by 50%, their motor behavior was stabilized, and histological analysis revealed increased numbers of myelinated axons and rescue of motoneuron number and size. This is the first report showing that a class of serine proteases (PAs) may be involved in the pathogenesis of a motor neuron disease and more specifically in axonal degeneration. Inhibiting serine proteases could offer a new strategy for delaying these disordersKeywords
This publication has 27 references indexed in Scilit:
- NeuroserpinFrontiers in Bioscience-Landmark, 2006
- A Role for the Plasminogen Activator System in Inflammation and Neurodegeneration in the Central Nervous System during Experimental Allergic EncephalomyelitisThe American Journal of Pathology, 2005
- Tissue plasminogen activator in central nervous system physiology and pathologyThrombosis and Haemostasis, 2005
- Motoneuron Resistance to Apoptotic Cell DeathIn VivoCorrelates with the Ratio between X-Linked Inhibitor of Apoptosis Proteins (XIAPs) and Its Inhibitor, XIAP-Associated Factor 1Journal of Neuroscience, 2004
- Missense mutation in the tubulin-specific chaperone E (Tbce) gene in the mouse mutant progressive motor neuronopathy, a model of human motoneuron diseaseJournal of Cell Biology, 2002
- A missense mutation in Tbce causes progressive motor neuronopathy in miceNature Genetics, 2002
- Mutation of TBCE causes hypoparathyroidism– retardation–dysmorphism and autosomal recessive Kenny–Caffey syndromeNature Genetics, 2002
- Microglial tissue plasminogen activator (tPA) triggers neuronal apoptosis in vitroGlia, 2000
- Polymer Encapsulated Cell Lines Genetically Engineered to Release Ciliary Neurotrophic Factor Can Slow Down Progressive Motor Neuronopathy in the MouseEuropean Journal of Neuroscience, 1995
- Plasminogen activators in the neuromuscular system of the wobbler mutant mouseBrain Research, 1992